# Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q7-good-manufacturing-practice-guidance-for-active-pharmaceutical-ingredients-guidance-for-industry/4c33ca12-225d-4a88-aaa5-3f0f8357fdd9

> FDA guidance document: Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Guidance for Industry. Issue date: September 30, 2016. Get complete insights and analysis.

---

## Details

- Title: Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-09-30
- Last Changed: 2020-04-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1995-D-0288">FDA-1995-D-0288</a>

## Related Documents

- [Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Questions and Answers Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/q7-good-manufacturing-practice-guidance-for-active-pharmaceutical-ingredients-questions-and-answers-guidance-for-industry/1600b7d2-35c2-41f8-add1-35f8c98ddb9b)
- [Contents of a Complete Submission for the Evaluation of Proprietary Names](https://www.globalkeysolutions.net/guidances/guidance-document/contents-of-a-complete-submission-for-the-evaluation-of-proprietary-names/8bbe789c-b7fd-4a76-9e78-6ea3344719df)
- [E2C(R2) Periodic Benefit-Risk Evaluation Report (PBRER)](https://www.globalkeysolutions.net/guidances/guidance-document/e2cr2-periodic-benefit-risk-evaluation-report-pbrer/34160d8d-51b7-47bd-a753-e6ad93180322)